Apex Biotechnology Corp.(TW:1733)
NT$28.60+0.05 (+0.18%)
TW:1733
Apex Biotechnology Corp. financials statements
NT$28.60
At close:+0.05 (+0.18%)
Apex Biotechnology Corp. (1733) Financial Statements
Apex Biotechnology Corp. Financial Overview
Apex Biotechnology Corp.'s market cap is currently NT$2.85B. The company's EPS TTM is NT$1.90; its P/E ratio is 15.05; and it has a dividend yield of 4.55%. Apex Biotechnology Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 1.94B | NT$ 1.85B | NT$ 1.68B | NT$ 2.24B | NT$ 2.13B |
| Gross Profit | NT$ 538.74M | NT$ 521.34M | NT$ 531.12M | NT$ 576.84M | NT$ 571.51M |
| Operating Income | NT$ 140.73M | NT$ 128.51M | NT$ 141.72M | NT$ 204.97M | NT$ 193.97M |
| EBITDA | NT$ 201.65M | NT$ 221.58M | NT$ 221.06M | NT$ 299.07M | NT$ 289.65M |
| Net Income | NT$ 163.04M | NT$ 128.00M | NT$ 115.78M | NT$ 181.78M | NT$ 202.22M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 644.37M | NT$ 598.78M | NT$ 443.91M | NT$ 397.53M | NT$ 631.25M |
| Total Assets | NT$ 2.42B | NT$ 2.42B | NT$ 2.30B | NT$ 2.51B | NT$ 2.67B |
| Total Debt | NT$ 148.86M | NT$ 166.16M | NT$ 180.83M | NT$ 243.91M | NT$ 343.28M |
| Net Debt | NT$ -418.23M | NT$ -366.52M | NT$ -201.22M | NT$ -87.80M | NT$ -212.06M |
| Total Liabilities | NT$ 545.32M | NT$ 595.70M | NT$ 500.07M | NT$ 696.81M | NT$ 916.91M |
| Stockholders' Equity | NT$ 1.87B | NT$ 1.82B | NT$ 1.80B | NT$ 1.82B | NT$ 1.75B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 148.88M | NT$ 299.04M | NT$ 205.41M | NT$ -13.58M | NT$ 153.67M |
| Operating Cash Flow | NT$ 164.14M | NT$ 328.67M | NT$ 230.39M | NT$ 26.62M | NT$ 179.87M |
| Investing Cash Flow | NT$ -5.54M | NT$ -35.60M | NT$ -22.50M | NT$ -41.37M | NT$ -35.02M |
| Financing Cash Flow | NT$ -132.68M | NT$ -148.67M | NT$ -168.14M | NT$ -237.60M | NT$ -351.27M |
Currency in TWD
